Project Grant K23MH138244
- The National Institute of Mental Health (NIMH) awarded a $242,827 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to Empowerx, Inc., a woman-owned small business in Del Mar, CA. The grant funding will support the development and assessment of the "PEP/PREP via Pharmacist-Prescribing Implementation (PEPPI)" software. The PEPPI software aims to improve access and adherence to HIV prevention therapies, including post-exposure prophylaxis (PEP) and...
- The National Institute of Mental Health (NIMH) awarded a $790,198 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to the University of Alabama at Birmingham (UAB) for the "PROTECT AL: PREP OPTIMIZATION THROUGH ENHANCED CONTINUUM TRACKING" project. The grant, awarded on September 18, 2025, aims to develop effective interventions to scale up and sustain HIV pre-exposure prophylaxis (PrEP) utilization in the Southern United States, a region disproportionately...
- This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) aims to optimize measurement and evaluate the health impacts of social, behavioral, and economic (SBE) stigmas among populations at risk for and living with HIV in the U.S. The $733,314 award will leverage the PLHIV Stigma Index 2.0 platform to collect attributional and non-attributional SBE stigma data, as well as qualitative data, across geographically...
- This $731,738 Project Grant awarded by the National Institute of Mental Health (CFDA 93.242 Mental Health Research Grants) will fund a pilot feasibility study to integrate pre-exposure prophylaxis (PrEP) into emergency department and urgent care settings using a patient-centered decision support tool. The goal is to improve PrEP awareness, access, and uptake among groups at highest risk for acquiring HIV, such as men who have sex with men, young people, racial/ethnic minorities, and women of...
- This federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $223,550 to the Icahn School of Medicine at Mount Sinai to conduct a pilot feasibility trial evaluating the impact of a point-of-care sexually transmitted infection (STI) testing strategy on improving HIV prevention service delivery in adolescents. The research aims to assess whether point-of-care testing for gonorrhea and chlamydia can...
- This federal Project Grant award titled "STREAMLINING TELEHEALTH FOR EXPANDED PREP UTILIZATION THROUGH COMMUNITY PARTNERSHIPS (STEP-UP)" is funded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242). The $744,279 award, effective from September 18, 2025 to September 17, 2028, supports the development and evaluation of an innovative model that positions community-based organizations (CBOs) as hubs for delivering pre-exposure...
- This federal Project Grant award for $657,907 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will support a 5-year longitudinal analysis to understand the impact of expanding pharmacists' scope of practice on the uptake and retention of pre-exposure prophylaxis (PrEP) for HIV prevention. The project aims to integrate multiple data sources, including policy, census, survey, and medical claims data, to...
- This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), supports research on the influence of social networks on HIV testing and pre-exposure prophylaxis (PrEP) care among young Latin American gay, bisexual, and other men who have sex with men (GBMSM). The $485,131 award to the New York Blood Center, Inc. is focused on understanding how social capital, social bonding, and network stress within the local and...
- This Project Grant award for $705,322.00, provided by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), aims to develop and test an AI-based chatbot intervention to promote HIV pre-exposure prophylaxis (PrEP) uptake among men who have sex with men (MSM) in Ending the HIV Epidemic (EHE) jurisdictions. The project, awarded to The Miriam Hospital, a division of Lifespan located in Rhode Island, will involve tailoring, refining, and...
- The University of South Florida (USF) received a $389,527 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) to conduct a study examining strategies and contextual factors that optimize the delivery of pre-exposure prophylaxis (PrEP) for HIV prevention in Kenya. The key products and services to be delivered through this two-year project include: Identifying implementation strategies and contextual factors that...
The National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), awarded a $191,117 project grant to The Regents of the University of California, San Francisco (UCSF) to develop and pilot an anti-stigma intervention aimed at improving personalized communication between pharmacy staff and individuals seeking pre-exposure prophylaxis (PrEP) for HIV prevention. The overarching goal is to adapt an existing effective anti-stigma intervention to the U.S. pharmacy context, with a focus on mitigating stigma experiences that can reduce PrEP initiation and ongoing use. The project involves three key activities: 1) qualitative research to understand the experiences and preferences of pharmacists, pharmacy technicians, and PrEP seekers regarding non-judgmental communication; 2) systematic adaptation of an existing anti-stigma intervention using the ADAPT-ITT framework to develop the "PRISM-P" intervention; and 3) piloting of the PRISM-P intervention with pharmacy staff in Northern California to assess feasibility, acceptability, and changes in beliefs about PrEP seekers. The award period is from September 1, 2025 to August 31, 2030.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $191.1k | 8/27/25 |